Dr. Saraswathi Saiprasad, MD
NPI: 1588977102
Total Payments
$2,910
2024 Payments
$618.42
Companies
38
Transactions
155
Medicare Patients
1,235
Medicare Billing
$139,656
Payment Breakdown by Category
Food & Beverage$2,910 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,910 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $375.81 | 9 | $0 (2024) |
| Lilly USA, LLC | $334.26 | 22 | $0 (2023) |
| Dexcom, Inc. | $230.14 | 8 | $0 (2024) |
| Novo Nordisk Inc | $171.06 | 11 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $151.89 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $146.86 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $141.64 | 9 | $0 (2020) |
| Insulet Corporation | $140.95 | 7 | $0 (2024) |
| Abbott Laboratories | $133.61 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $104.04 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $618.42 | 28 | Insulet Corporation ($76.62) |
| 2023 | $312.84 | 12 | Dexcom, Inc. ($133.73) |
| 2022 | $13.51 | 1 | Abbott Laboratories ($13.51) |
| 2021 | $80.99 | 5 | Lilly USA, LLC ($17.56) |
| 2020 | $260.51 | 14 | Novartis Pharmaceuticals Corporation ($58.20) |
| 2019 | $533.66 | 26 | Amgen Inc. ($125.00) |
| 2018 | $585.60 | 32 | Amgen Inc. ($158.15) |
| 2017 | $503.97 | 37 | Lilly USA, LLC ($124.08) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 5 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 06/18/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $10.56 | General |
| Category: Cardiovascular | ||||||
| 06/12/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology | ||||||
| 06/11/2018 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes | ||||||
| 05/29/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 05/22/2018 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes | ||||||
| 05/18/2018 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: Bone Muscle Joint | ||||||
| 04/25/2018 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Endocrinology | ||||||
| 04/10/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/06/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $14.75 | General |
| Category: NEUROLOGY | ||||||
| 03/20/2018 | Novo Nordisk Inc | FIASP (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Diabetes | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: DIABETES | ||||||
| 02/22/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 02/20/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/09/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/29/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Sleep | ||||||
| 01/15/2018 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 12/15/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/11/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 12/11/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Diabetes | ||||||
| 12/01/2017 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $10.91 | General |
| Category: Sleep | ||||||
| 11/20/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 11/18/2017 | Abbott Laboratories | FreeStyle Libre Pro (Device), FreeStyle Libre Pro, FreeStyle Libre Pro | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes Care | ||||||
| 11/13/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 221 | 330 | $67,679 | $25,846 |
| 2022 | 6 | 220 | 329 | $66,182 | $23,401 |
| 2021 | 8 | 411 | 600 | $124,940 | $51,208 |
| 2020 | 6 | 383 | 559 | $107,683 | $39,201 |
Total Patients
1,235
Total Services
1,818
Medicare Billing
$139,656
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 109 | $25,966 | $10,727 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $15,786 | $6,401 | 40.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $9,827 | $3,675 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $6,707 | $2,720 | 40.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 23 | 66 | $8,373 | $1,820 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 60 | $1,020 | $504.00 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 98 | 146 | $27,740 | $9,314 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 33 | 55 | $14,520 | $5,747 | 39.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 24 | 24 | $9,792 | $2,971 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $4,135 | $1,722 | 41.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2022 | 21 | 54 | $3,996 | $1,474 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $3,887 | $1,198 | 30.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 16 | $2,112 | $975.11 | 46.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 61 | 101 | $25,504 | $11,527 | 45.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 95 | 127 | $23,382 | $9,059 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 83 | $20,073 | $8,844 | 44.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 42 | 42 | $16,921 | $6,095 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 72 | $12,949 | $5,281 | 40.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $8,632 | $2,954 | 34.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 22 | $3,976 | $2,084 | 52.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $4,123 | $1,553 | 37.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Facility | 2021 | 26 | 50 | $3,700 | $1,381 | 37.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 17 | $2,124 | $1,200 | 56.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 15 | 24 | $1,632 | $626.36 | 38.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 16 | 26 | $1,924 | $604.38 | 31.4% |
About Dr. Saraswathi Saiprasad, MD
Dr. Saraswathi Saiprasad, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588977102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saraswathi Saiprasad, MD has received a total of $2,910 in payments from pharmaceutical and medical device companies, with $618.42 received in 2024. These payments were reported across 155 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($2,910).
As a Medicare-enrolled provider, Saiprasad has provided services to 1,235 Medicare beneficiaries, totaling 1,818 services with total Medicare billing of $139,656. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Fort Worth, TX
- Active Since 07/24/2010
- Last Updated 12/06/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1588977102
Products in Payments
- Prolia (Biological) $153.57
- AIMOVIG (Biological) $141.64
- Omnipod (Device) $140.95
- BASAGLAR (Drug) $129.93
- JARDIANCE (Drug) $117.28
- JANUVIA (Drug) $114.16
- DEXCOM G7 GSS (161) (Medical Supply) $106.77
- FARXIGA (Drug) $88.23
- Victoza (Drug) $83.81
- FREESTYLE LIBRE (Device) $83.16
- Ozempic (Drug) $75.13
- HUMULIN (Drug) $74.97
- MINIMED 780G (Device) $62.97
- INVOKANA (Drug) $61.00
- RenovaRP (Device) $54.88
- Dexcom G6 Transmitter (Medical Supply) $51.47
- Korlym (Drug) $51.26
- Enbrel (Biological) $50.41
- LUPKYNIS (Drug) $48.38
- Tymlos (Biological) $45.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Fort Worth
Anjanette Tan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $303,907
Endocrinology, Diabetes & Metabolism $303,907
Dr. Chris Bajaj, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $268,642
Endocrinology, Diabetes & Metabolism $268,642
Dr. David Wilson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $232,835
Endocrinology, Diabetes & Metabolism $232,835
Dr. Kenneth Mair, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $107,541
Endocrinology, Diabetes & Metabolism $107,541
Joel Steelman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $48,218
Endocrinology, Diabetes & Metabolism $48,218
Dr. Franklin Gluck, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,599
Endocrinology, Diabetes & Metabolism $1,599